This study is looking at a new way to use a special type of CT scan, called spectral CT, during procedures for liver and kidney cancer. It's an observational study, meaning researchers will watch and learn how this technology works during image-guided embolization (blocking blood flow to a tumor) and ablation (destroying a tumor with heat or cold). The goal is to see if spectral CT can help doctors better see tumors, guide treatments, and understand how well treatments are working. You might be able to join if you are at least 18 years old and have liver or kidney cancer with a tumor larger than 1.5 cm that hasn't been treated with surgery or ablation before. The study aims to enroll 30 participants.

Study design

This is an observational study that aims to enroll 30 participants. It is not specified if it is randomized or blinded.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, CT image, is measured at baseline, so long-term follow-up is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.